Neoadjuvant chemotherapy with oxaliplatin and capecitabine versus chemoradiation with capecitabine for locally advanced rectal cancer with uninvolved mesorectal fascia (CONVERT): Initial results of a multicenter randomised, open-label, phase III trial
机构:[1]Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China[2]General Surgery, Shantou Central Hospital (Affiliated Shantou Hospital of Sun Yat-sen University), Shantou, China[3]Colorectal Surgery, Yunnan Cancer Hospital/The Third Affiliated Hospital of Kunming Medical University, Kunming, China[4]Colorectal Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China江苏省人民医院[5]Gastrointestinal Surgical Oncology, Fujian Medical University Cancer Hospital & Fujian Cancer Hospital, Fuzhou, China[6]Department of Gastrointestinal Surgery, Meizhou People’s Hospital, Meizhou, China[7]Colorectal Surgery, Liaoning Cancer Hospital, Shenyang, China[8]Department of Gastrointestinal Surgery, Guangdong Provincial Hospital of Chinese Medicine, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China广东省中医院[9]Gastrointestinal Surgery, Guangdong Provincial People`s Hospital, Guangzhou, China[10]Abdominal Surgery, Cancer Hospital of Shantou University Medical College, Shantou, China[11]Gastroenterology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China[12]Department of General Surgery, Henan Cancer Hospital & The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China河南省肿瘤医院[13]Department of Gastrointestinal Surgery, The First Affiliated Hospital of ChongQing Medical University, Chongqing, China重庆医科大学附属第一医院[14]Surgical Oncology, First Affiliated Hospital of Kunming Medical University, Kunming, China内科科室肿瘤内科昆明医科大学附属第一医院[15]Department of Gastrointestinal Surgery, West China Hospital of Sichuan University, Sichuan, China四川大学华西医院[16]Department of Radiotherapy, Sun Yat-sen University Cancer Center, Guangzhou, China
第一作者机构:[1]Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China
推荐引用方式(GB/T 7714):
Ding PR.,Wang XZ.,Li YF.,et al.Neoadjuvant chemotherapy with oxaliplatin and capecitabine versus chemoradiation with capecitabine for locally advanced rectal cancer with uninvolved mesorectal fascia (CONVERT): Initial results of a multicenter randomised, open-label, phase III trial[J].ANNALS OF ONCOLOGY.2021,32:S1296-S1296.doi:10.1016/j.annonc.2021.08.2096.
APA:
Ding, PR.,Wang, XZ.,Li, YF.,Sun, YM.,Yang, CK....&Wan, DS..(2021).Neoadjuvant chemotherapy with oxaliplatin and capecitabine versus chemoradiation with capecitabine for locally advanced rectal cancer with uninvolved mesorectal fascia (CONVERT): Initial results of a multicenter randomised, open-label, phase III trial.ANNALS OF ONCOLOGY,32,
MLA:
Ding, PR.,et al."Neoadjuvant chemotherapy with oxaliplatin and capecitabine versus chemoradiation with capecitabine for locally advanced rectal cancer with uninvolved mesorectal fascia (CONVERT): Initial results of a multicenter randomised, open-label, phase III trial".ANNALS OF ONCOLOGY 32.(2021):S1296-S1296